Learn how the molecule EBC-46 could advance how HIV is treated and how researchers discovered it.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now a new study led by Stanford researchers has revealed that EBC-46 also shows ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

Ongoing research investigating how HIV remains as a latent reservoir in resting T helper cells to ensure viral persistence in patients that have undergone treatment with highly active antiretroviral ...

A multi-pronged approach will likely be needed to achieve the goal of curing HIV. The discovery and development of latency-reversing agents, immune modulators, and genetically engineered effector ...

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating HIV. Acting as a potent latency-reversing agent, EBC-46 activates dormant ...

Dr. Shen has ongoing research studying latent reservoirs of HIV infection. She is investigating the mechanisms of how the reservoirs are formed and potential ways to remove the latent reservoir. Her ...